Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

XTRA:BAYN
XTRA:BAYNPharmaceuticals

Will OCEANIC-STROKE’s Asundexian Data Shift Bayer’s (XTRA:BAYN) Narrative on Innovation and Risk?

In early February 2026, Bayer reported pivotal Phase III OCEANIC-STROKE results showing its investigational Factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major bleeding versus placebo, both on top of antiplatelet therapy. A key insight from OCEANIC-STROKE is that asundexian delivered stroke risk reduction across all enrolled TOAST stroke subtypes, while maintaining a bleeding profile comparable to placebo. Against this backdrop, we’ll examine how the...
NYSE:HXL
NYSE:HXLAerospace & Defense

Assessing Hexcel (HXL) Valuation After Strong Recent Share Price Momentum

Hexcel’s recent performance and what it could mean for investors Hexcel (HXL) has attracted fresh attention after a strong past 3 months, with the stock showing a 25.03% total return and a 32.49% total return over the past year. See our latest analysis for Hexcel. At a share price of $86.06, Hexcel’s recent 7 day and 90 day share price returns of 5.48% and 25.03% sit alongside a 32.49% 1 year total shareholder return. This suggests momentum has been building rather than fading. If Hexcel’s...
ASX:CBA
ASX:CBABanks

Commonwealth Bank Half Year Results Test Quality Of Earnings And Dividends

Commonwealth Bank of Australia (ASX:CBA) is preparing to release its half year results, including an interim dividend announcement. The figures will incorporate one off impacts from ASIC’s Better Banking review regulatory provisions. Results will also reflect non recurring income from the sale of Commonwealth Insurance Limited and a fair value uplift in CBA’s Gemini stake. CBA is adjusting home loan rates in response to recent Reserve Bank of Australia cash rate hikes, which will flow...